GemPharmatech (688046)
Overview
GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, cus
Employees1590
Market Cap$7.1B
Revenue$830.6M
Listed OnShanghai Stock Exchange
Ticker688046
CEODr. Xiang Gao Ph.D.
HeadquartersNanjing